share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Officer Sprague John M

SEC announcement ·  Feb 20 16:06
Summary by Moomoo AI
John M. Sprague, the Chief Financial Officer of T2 Biosystems, Inc. (TTOO), executed a transaction on February 20, 2024, involving the acquisition of 40 shares of common stock. The transaction, classified under the code 'M', indicates an exercise or conversion of derivative security. Following this transaction, Sprague's direct holdings in the company increased to a total of 112 shares of common stock. The action reflects a continued investment by the CFO in the company, signaling potential confidence in T2 Biosystems' future performance.
John M. Sprague, the Chief Financial Officer of T2 Biosystems, Inc. (TTOO), executed a transaction on February 20, 2024, involving the acquisition of 40 shares of common stock. The transaction, classified under the code 'M', indicates an exercise or conversion of derivative security. Following this transaction, Sprague's direct holdings in the company increased to a total of 112 shares of common stock. The action reflects a continued investment by the CFO in the company, signaling potential confidence in T2 Biosystems' future performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more